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When we received this invitation from Intensive Care 
Medicine, it initially filled us with enthusiasm but soon 
turned out to be a very difficult task. It is not just that 
we are neither fortune-tellers nor health economists, but 
we are also biased as we have a major interest in perio-
perative hemodynamic optimization [1–3], which is just 
one piece of the whole puzzle. On top of this we will be 
well within retirement age in 2050, if alive at all. But it 
is beyond doubt that the current generation has a huge 
responsibility in how medicine will look in the future. 
Therefore, the purpose of this paper is to highlight some 
aspects and trends from the present which may deter-
mine changes in the upcoming decades.
Within the next 30 years, changes in perioperative crit-
ical care will be driven by several factors, such as epide-
miologic, socioeconomic, and scientific ones. However, 
the arising challenges will be different in various parts 
of the world. In developing countries—and thus affect-
ing the majority of the world’s population—many more 
patients than today will demand complex surgical treat-
ments. Although the number of people who can have 
access to high-end medical services, considered as the 
gold standard in Europe and the USA, will increase, this 
will remain out of reach for the majority. Perhaps, an 
“economy of scale” also in perioperative medicine will 
be, at least in part, a solution in these countries: complex 
surgery with the need for perioperative intensive care will 
not be provided everywhere, but in large centers—and in 
dimensions much larger than those known today. And 
this is, from the authors’ point of view, more desirable 
than refusing care at all to those people. The tremendous 
increase in cardiac surgery services in India serves as an 
example of this [4].
Developed countries will also face special challenges. 
Recent results of the ISOS trial demonstrated that in 
regards to surgical outcome—with the emphasis on 
quality (i.e., morbidity)—there is still room for improve-
ment [5]. Hopefully, by 2050 medical service providers 
will acknowledge that reimbursement should not only 
depend on quantity but also on certain measures of qual-
ity, which will put (hopefully positive) pressure on perio-
perative intensive care [6].
The ageing patient population may also have a signifi-
cant effect on intensive care in 2050. In 2005, 16.6% of 
Europeans were older than 65; in 2015, this proportion 
had already increased to 18%; and in 2050, it is estimated 
to reach more than 28% [7]. Changes in America, Asia, 
and Africa will be similar or even more profound, and 
although (and also because) the overall health status of 
the elderly will further improve, specific perioperative 
treatment concepts for this particular patient group will 
reach critical importance.
These changes in circumstances render the need for a 
paradigm shift in perioperative intensive care, which has 
already resulted in the development of a relatively new 
medical field called “perioperative medicine”. This should 
provide a more efficient and focused approach as com-
pared to the contemporary structure in which patients 
are managed more or less independently by physicians, 
surgeons, anesthesiologists, and intensivists [5, 8]. This 
concept is still developing but its potential importance 
will generate more reviews and opinions dedicated solely 
to this subject in the future. For elective high-risk cases, 
the use of “enhanced recovery programs” [9], homeosta-
sis-optimizing treatments (a future step in contempo-
rary goal-directed treatments) [10] with a combination 
of minimally or even non-invasive treatment modali-
ties replacing in part contemporary extensive surgical 
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approaches and efforts to attenuate the undesired effects 
of major surgery such as postoperative hypoxemia [11] 
and renal dysfunction [12, 13], will aim to shorten or 
even omit postoperative hospitalization. Smart wearables 
will help in managing remote vigilance over the patient’s 
vital function [14] and nanotechnology may improve 
the use of prolonged loco-regional analgesic techniques 
significantly, leaving patients pain-free and able to reha-
bilitate swiftly both enabling “at-home” postoperative 
course (Fig.  1) [15]. Whether robotic surgery or even 
machine-controlled autonomic patient care in the oper-
ating room and on the ICU will push surgeons, anesthe-
siologists, intensivists, and nursing staff for the most part 
aside, sounds scary and (hopefully) unrealistic—practic-
ing medicine is intrinsically tied to altruism and empa-
thy. However, in 1967 nobody thought about autonomic 
traffic on our roads, and a similar automatization and 
robotic care in perioperative medicine may actually lead 
to minimization of human errors in some instances. But 
will this make perioperative intensive care in its current 
form more or less unnecessary in the future? We do not 
believe so.
In line with this, one can hardly predict the speed at 
which technological developments will take place and 
affect our practice. But it may not be science fiction that 
the majority of preoperative assessments could be done 
via online communications or smart wearables. Highly 
sophisticated apps could check and analyze physiologi-
cal, even laboratory parameters and perform a swift risk 
assessment within minutes, avoiding the need for attend-
ance for anesthetic pre-assessment in hospitals. Genetic 
pretesting could play a role in predicting patients’ 
response to major surgery, hence identifying those at 
high risk for developing postoperative complications. 
This will further open the door for even more individual-
ized perioperative treatment strategies, bringing us away 
from “one size fits all” approaches. New-generation anes-
thetics, analgesics, and muscle relaxants with fast onset/
short half-life will be administered using automatic and 
partially autonomous closed loop systems applying indi-
vidualized pharmacokinetic models and intelligent neu-
ral networks to tailor drug delivery to the patients’ need. 
Contemporary methods of intraoperative monitoring will 
be replaced by devices enabling the analysis of multiple 
domains and their interactions, including complex evalu-
ation of heart and lung function, which will be put it in 
the context of depth of anesthesia and degree of analgesia. 
Most of such monitors will be wireless, gaining informa-
tion from non-invasive or semi-invasive modules and also 
linked to each other. Such systems will allow skilled anes-
thesiologists to keep more anesthetic stations under con-
trol, hence facilitate training and improve patient safety.
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Fig. 1 Perioperative treatment pathways. Colors correspond to pre- (green), intra- (blue), and postoperative (red) care. See text for explanation
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Regarding major disasters, the basics of care, such as 
immediate resuscitation, pain relief, and damage control 
surgery, will most likely remain as today, but revolution-
ary changes may also take place, such as introducing sus-
pended animation [16], artificial blood and tissues [17], 
modulating systemic inflammation, and treating molecu-
lar effects of injury on cellular or even subcellular levels 
[18]. But of course, every solution for a certain problem 
will inevitably bring up new ones. Therefore, every new 
development will have its own side effects and risks, 
which will have to be solved by the generations coming 
after 2050.
Finally, in addition to trying to evaluate current trends 
and predict how perioperative critical care will look 
(Supplementary Table 1), we also asked ourselves how we 
would like it to be in 2050? It may be completely differ-
ent compared to what we have predicted, but one thing 
should not change and it is of utmost importance: the 
quality of caring staff with the patient in focus. Nothing, 
not even hi-tech autonomous robotic systems, should 
ever replace the devoted, well-trained, thinking, and car-
ing physicians and nurses either today or in 2050. Hence 
the motto should remain the same: “And as you wish that 
others would do to you, do so to them”. (Luke 6,31).
Electronic supplementary material
The online version of this article (doi:10.1007/s00134-017-4703-6) contains 
supplementary material, which is available to authorized users.
Author details
1 Department of Anesthesiology and Intensive Care, University of Szeged, 
6. Semmelweis St, Szeged 6725, Hungary. 2 Department of Anesthesiol-
ogy and Intensive Care, Faculty of Medicine in Plzen, Charles University, 
alej Svobody 80, 306 40 Plzen, Czech Republic. 3 Biomedical Centre, Faculty 
of Medicine in Plzen, Charles University, alej Svobody 76, 323 00 Plzen, Czech 
Republic. 4 Center of Anesthesiology and Intensive Care Medicine, Hamburg 
Eppendorf University Medical Center, Martinistr. 52, 20246 Hamburg, Germany. 
Received: 4 January 2017   Accepted: 27 January 2017
Published online: 8 February 2017
References
 1. Salzwedel C, Puig J, Carstens A et al (2013) Perioperative goal-directed 
hemodynamic therapy based on radial arterial pulse pressure varia-
tion and continuous cardiac index trending reduces postoperative 
complications after major abdominal surgery: a multi-center, prospective, 
randomized study. Crit Care 17:R191
 2. Benes J, Chytra I, Altmann P et al (2010) Intraoperative fluid optimization 
using stroke volume variation in high risk surgical patients: results of 
prospective randomized study. Crit Care 14:R118
 3. Mikor A, Trasy D, Nemeth MF et al (2015) Continuous central venous 
oxygen saturation assisted intraoperative hemodynamic management 
during major abdominal surgery: a randomized, controlled trial. BMC 
Anesthesiol 15:82. doi:10.1186/s12871-015-0064-2
 4. Govindarajan V, Ramamurti R (2013) India’s secret to low cost health care. 
Harvard Business Review. https://hbr.org/2013/10/indias-secret-to-low-
cost-health-care. Accessed 19 Dec 2016
 5. The International Surgical Outcomes Study group (2016) Global patient 
outcomes after elective surgery: prospective cohort study in 27 low-, 
middle- and high-income countries. Br J Anaesth 117:601–609
 6. Porter ME, Lee TH (2013) The strategy that will fix healthcare. Harvard 
Business Review. https://hbr.org/2013/10/the-strategy-that-will-fix-
health-care. Accessed 19 Dec 2016
 7. European Commission. Eurostat: http://ec.europa.eu/eurostat/statistics-
explained. Accessed 19 Dec 2016
 8. Grocott MP, Pearse RM (2012) Perioperative medicine: the future of anaes-
thesia? Br J Anaesth 108:723–726
 9. Thiele RH, Raghunathan K, Brudney CS et al (2016) American Society for 
Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) 
joint consensus statement on perioperative fluid management within an 
enhanced recovery pathway for colorectal surgery. Perioper Med 5:24. 
doi:10.1186/s13741-016-0049-9
 10. Futier E, Paugam-Burtz C, Godet T, Khoy-Ear L, Rozencwajg S, Delay JM, 
Verzilli D, Dupuis J, Chanques G, Bazin JE, Constantin JM, Pereira B, Jaber 
S, OPERA study investigators (2016) Effect of early postextubation high-
flow nasal cannula vs conventional oxygen therapy on hypoxaemia in 
patients after major abdominal surgery: a French multicentre randomised 
controlled trial (OPERA). Intensive Care Med 42:1888–1898
 11. Tanczos K, Nemeth M, Molnar Z (2015) What’s new in hemorrhagic 
shock? Intensive Care Med 41:712–714
 12. O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR (2016) Incidence and asso-
ciations of acute kidney injury after major abdominal surgery. Intensive 
Care Med 42:521–530
 13. Mårtensson J, Bellomo R (2015) What’s new in perioperative renal dys-
function? Intensive Care Med 41:514–516
 14. Michard F (2016) Hemodynamic monitoring in the era of digital health. 
Ann Intensive Care 6:15. doi:10.1186/s13613-016-0119-7
 15. Mantha VRR, Nair HK, Venkataramanan R et al (2014) Nanoanesthesia: a 
novel, intravenous approach to ankle block in the rat by magnet-directed 
concentration of ropivacaine-associated nanoparticles. Aesth Analg 
118:1355–1362
 16. Asfar P, Radermacher P (2015) Drug-induced “suspended animation”: can 
a dream come true? Crit Care Med 43:1528–1530
 17. Chang TMS (2012) From artificial blood cells, oxygen carriers, and oxygen 
therapeutics to artificial cells, nanomedicine and beyond. Artif Cells 
Blood Substit Immobil Biotechnol 40:197–199
 18. Dumont CM, Park J, Shea LD (2015) Controlled release strategies for 
modulating immune responses to promote tissue regeneration. J Control 
Release 219:155–166
